Table of Content

1 Market Overview of Injectable Peptides
1.1 Injectable Peptides Market Overview
1.1.1 Injectable Peptides Product Scope
1.1.2 Injectable Peptides Market Status and Outlook
1.2 Global Injectable Peptides Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Injectable Peptides Market Size by Region (2024-2034)
1.4 Global Injectable Peptides Historic Market Size by Region (2024-2024)
1.5 Global Injectable Peptides Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Injectable Peptides Market Size (2024-2034)
1.6.1 North America Injectable Peptides Market Size (2024-2034)
1.6.2 Europe Injectable Peptides Market Size (2024-2034)
1.6.3 Asia-Pacific Injectable Peptides Market Size (2024-2034)
1.6.4 Latin America Injectable Peptides Market Size (2024-2034)
1.6.5 Middle East & Africa Injectable Peptides Market Size (2024-2034)
2 Injectable Peptides Market by Type
2.1 Introduction
2.1.1 Brand
2.1.2 Generic Drug
2.2 Global Injectable Peptides Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Injectable Peptides Historic Market Size by Type (2024-2024)
2.2.2 Global Injectable Peptides Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Injectable Peptides Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Injectable Peptides Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Injectable Peptides Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Injectable Peptides Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Injectable Peptides Revenue Breakdown by Type (2024-2034)
3 Injectable Peptides Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Metabolic Disorders
3.1.3 Central Nervous System
3.1.4 Other
3.2 Global Injectable Peptides Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Injectable Peptides Historic Market Size by Application (2024-2024)
3.2.2 Global Injectable Peptides Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Injectable Peptides Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Injectable Peptides Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Injectable Peptides Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Injectable Peptides Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Injectable Peptides Revenue Breakdown by Application (2024-2034)
4 Injectable Peptides Competition Analysis by Players
4.1 Global Injectable Peptides Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Peptides as of 2022)
4.3 Date of Key Players Enter into Injectable Peptides Market
4.4 Global Top Players Injectable Peptides Headquarters and Area Served
4.5 Key Players Injectable Peptides Product Solution and Service
4.6 Competitive Status
4.6.1 Injectable Peptides Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Injectable Peptides Products, Services and Solutions
5.1.4 Sanofi Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.1.5 Sanofi Recent Developments
5.2 Teva
5.2.1 Teva Profile
5.2.2 Teva Main Business
5.2.3 Teva Injectable Peptides Products, Services and Solutions
5.2.4 Teva Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.2.5 Teva Recent Developments
5.3 Novo Nordisk
5.3.1 Novo Nordisk Profile
5.3.2 Novo Nordisk Main Business
5.3.3 Novo Nordisk Injectable Peptides Products, Services and Solutions
5.3.4 Novo Nordisk Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Injectable Peptides Products, Services and Solutions
5.4.4 Takeda Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.4.5 Takeda Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Injectable Peptides Products, Services and Solutions
5.5.4 Eli Lilly Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.5.5 Eli Lilly Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Injectable Peptides Products, Services and Solutions
5.6.4 AstraZeneca Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.6.5 AstraZeneca Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Injectable Peptides Products, Services and Solutions
5.7.4 Novartis Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.7.5 Novartis Recent Developments
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business
5.8.3 AbbVie Injectable Peptides Products, Services and Solutions
5.8.4 AbbVie Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.8.5 AbbVie Recent Developments
5.9 Ipsen
5.9.1 Ipsen Profile
5.9.2 Ipsen Main Business
5.9.3 Ipsen Injectable Peptides Products, Services and Solutions
5.9.4 Ipsen Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.9.5 Ipsen Recent Developments
5.10 Ferring
5.10.1 Ferring Profile
5.10.2 Ferring Main Business
5.10.3 Ferring Injectable Peptides Products, Services and Solutions
5.10.4 Ferring Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.10.5 Ferring Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Injectable Peptides Products, Services and Solutions
5.11.4 Merck Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.11.5 Merck Recent Developments
5.12 The Medicines
5.12.1 The Medicines Profile
5.12.2 The Medicines Main Business
5.12.3 The Medicines Injectable Peptides Products, Services and Solutions
5.12.4 The Medicines Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.12.5 The Medicines Recent Developments
5.13 Roche
5.13.1 Roche Profile
5.13.2 Roche Main Business
5.13.3 Roche Injectable Peptides Products, Services and Solutions
5.13.4 Roche Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.13.5 Roche Recent Developments
5.14 J & J
5.14.1 J & J Profile
5.14.2 J & J Main Business
5.14.3 J & J Injectable Peptides Products, Services and Solutions
5.14.4 J & J Injectable Peptides Revenue (US$ Million) & (2024-2024)
5.14.5 J & J Recent Developments
6 North America
6.1 North America Injectable Peptides Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Injectable Peptides Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Injectable Peptides Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Injectable Peptides Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Injectable Peptides Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Injectable Peptides Market Dynamics
11.1 Injectable Peptides Industry Trends
11.2 Injectable Peptides Market Drivers
11.3 Injectable Peptides Market Challenges
11.4 Injectable Peptides Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Injectable Peptides Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Injectable Peptides Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Injectable Peptides Market Size Share by Region (2024-2024)
Table 4. Global Injectable Peptides Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Injectable Peptides Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Injectable Peptides Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Injectable Peptides Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Injectable Peptides Revenue Market Share by Type (2024-2024)
Table 9. Global Injectable Peptides Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Injectable Peptides Revenue Market Share by Type (2024-2034)
Table 11. North America Injectable Peptides Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Injectable Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Injectable Peptides Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Injectable Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Injectable Peptides Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Injectable Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Injectable Peptides Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Injectable Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Injectable Peptides Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Injectable Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Injectable Peptides Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Injectable Peptides Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Injectable Peptides Revenue Market Share by Application (2024-2024)
Table 24. Global Injectable Peptides Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Injectable Peptides Revenue Market Share by Application (2024-2034)
Table 26. North America Injectable Peptides Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Injectable Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Injectable Peptides Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Injectable Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Injectable Peptides Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Injectable Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Injectable Peptides Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Injectable Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Injectable Peptides Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Injectable Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Injectable Peptides Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Injectable Peptides Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Peptides as of 2022)
Table 39. Date of Key Players Enter into Injectable Peptides Market
Table 40. Global Injectable Peptides Key Players Headquarters and Area Served
Table 41. Injectable Peptides Product Solution and Service
Table 42. Global Injectable Peptides Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Sanofi Basic Information List
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Injectable Peptides Products, Services and Solutions
Table 47. Revenue (US$ Million) in Injectable Peptides Business of Sanofi (2024-2024)
Table 48. Sanofi Recent Developments
Table 49. Teva Basic Information List
Table 50. Teva Description and Business Overview
Table 51. Teva Injectable Peptides Products, Services and Solutions
Table 52. Revenue (US$ Million) in Injectable Peptides Business of Teva (2024-2024)
Table 53. Teva Recent Developments
Table 54. Novo Nordisk Basic Information List
Table 55. Novo Nordisk Description and Business Overview
Table 56. Novo Nordisk Injectable Peptides Products, Services and Solutions
Table 57. Revenue (US$ Million) in Injectable Peptides Business of Novo Nordisk (2024-2024)
Table 58. Novo Nordisk Recent Developments
Table 59. Takeda Basic Information List
Table 60. Takeda Description and Business Overview
Table 61. Takeda Injectable Peptides Products, Services and Solutions
Table 62. Revenue (US$ Million) in Injectable Peptides Business of Takeda (2024-2024)
Table 63. Takeda Recent Developments
Table 64. Eli Lilly Basic Information List
Table 65. Eli Lilly Description and Business Overview
Table 66. Eli Lilly Injectable Peptides Products, Services and Solutions
Table 67. Revenue (US$ Million) in Injectable Peptides Business of Eli Lilly (2024-2024)
Table 68. Eli Lilly Recent Developments
Table 69. AstraZeneca Basic Information List
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Injectable Peptides Products, Services and Solutions
Table 72. Revenue (US$ Million) in Injectable Peptides Business of AstraZeneca (2024-2024)
Table 73. AstraZeneca Recent Developments
Table 74. Novartis Basic Information List
Table 75. Novartis Description and Business Overview
Table 76. Novartis Injectable Peptides Products, Services and Solutions
Table 77. Revenue (US$ Million) in Injectable Peptides Business of Novartis (2024-2024)
Table 78. Novartis Recent Developments
Table 79. AbbVie Basic Information List
Table 80. AbbVie Description and Business Overview
Table 81. AbbVie Injectable Peptides Products, Services and Solutions
Table 82. Revenue (US$ Million) in Injectable Peptides Business of AbbVie (2024-2024)
Table 83. AbbVie Recent Developments
Table 84. Ipsen Basic Information List
Table 85. Ipsen Description and Business Overview
Table 86. Ipsen Injectable Peptides Products, Services and Solutions
Table 87. Revenue (US$ Million) in Injectable Peptides Business of Ipsen (2024-2024)
Table 88. Ipsen Recent Developments
Table 89. Ferring Basic Information List
Table 90. Ferring Description and Business Overview
Table 91. Ferring Injectable Peptides Products, Services and Solutions
Table 92. Revenue (US$ Million) in Injectable Peptides Business of Ferring (2024-2024)
Table 93. Ferring Recent Developments
Table 94. Merck Basic Information List
Table 95. Merck Description and Business Overview
Table 96. Merck Injectable Peptides Products, Services and Solutions
Table 97. Revenue (US$ Million) in Injectable Peptides Business of Merck (2024-2024)
Table 98. Merck Recent Developments
Table 99. The Medicines Basic Information List
Table 100. The Medicines Description and Business Overview
Table 101. The Medicines Injectable Peptides Products, Services and Solutions
Table 102. Revenue (US$ Million) in Injectable Peptides Business of The Medicines (2024-2024)
Table 103. The Medicines Recent Developments
Table 104. Roche Basic Information List
Table 105. Roche Description and Business Overview
Table 106. Roche Injectable Peptides Products, Services and Solutions
Table 107. Revenue (US$ Million) in Injectable Peptides Business of Roche (2024-2024)
Table 108. Roche Recent Developments
Table 109. J & J Basic Information List
Table 110. J & J Description and Business Overview
Table 111. J & J Injectable Peptides Products, Services and Solutions
Table 112. Revenue (US$ Million) in Injectable Peptides Business of J & J (2024-2024)
Table 113. J & J Recent Developments
Table 114. North America Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 115. North America Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 116. Europe Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 117. Europe Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 118. Asia-Pacific Injectable Peptides Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 119. Asia-Pacific Injectable Peptides Market Size by Region (2024-2024) & (US$ Million)
Table 120. Asia-Pacific Injectable Peptides Market Size by Region (2024-2034) & (US$ Million)
Table 121. Asia-Pacific Injectable Peptides Market Share by Region (2024-2024)
Table 122. Asia-Pacific Injectable Peptides Market Share by Region (2024-2034)
Table 123. Latin America Injectable Peptides Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 124. Latin America Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 125. Latin America Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 126. Middle East & Africa Injectable Peptides Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 127. Middle East & Africa Injectable Peptides Market Size by Country (2024-2024) & (US$ Million)
Table 128. Middle East & Africa Injectable Peptides Market Size by Country (2024-2034) & (US$ Million)
Table 129. Injectable Peptides Market Trends
Table 130. Injectable Peptides Market Drivers
Table 131. Injectable Peptides Market Challenges
Table 132. Injectable Peptides Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Peptides Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Injectable Peptides Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Injectable Peptides Market Share by Regions: 2022 VS 2034
Figure 4. Global Injectable Peptides Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Injectable Peptides Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Injectable Peptides Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Injectable Peptides Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Injectable Peptides Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Injectable Peptides Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Brand
Figure 11. Global Brand Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Generic Drug
Figure 13. Global Generic Drug Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Injectable Peptides Market Size Share by Type: 2022 & 2034
Figure 15. North America Injectable Peptides Revenue Market Share by Type (2024-2034)
Figure 16. Europe Injectable Peptides Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Injectable Peptides Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Injectable Peptides Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Injectable Peptides Revenue Market Share by Type (2024-2034)
Figure 20. Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Metabolic Disorders Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Central Nervous System Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Injectable Peptides Market Size Share by Application: 2022 & 2034
Figure 25. North America Injectable Peptides Revenue Market Share by Application (2024-2034)
Figure 26. Europe Injectable Peptides Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Injectable Peptides Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Injectable Peptides Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Injectable Peptides Revenue Market Share by Application (2024-2034)
Figure 30. Injectable Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Injectable Peptides Market Share in 2022
Figure 32. North America Injectable Peptides Market Share by Country (2024-2034)
Figure 33. United States Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 36. France Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Injectable Peptides Market Share by Region (2024-2034)
Figure 42. China Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 46. India Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Injectable Peptides Market Share by Country (2024-2034)
Figure 49. Mexico Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Injectable Peptides Market Share by Country (2024-2034)
Figure 52. Turkey Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Injectable Peptides Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report